The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men

Research Article
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men

S. B. Haugaard, O. Andersen, T. W. Hansen, J. Eugen-Olsen, A. Linneberg, S. Madsbad, M. H. Olsen, T. Jorgensen, K. Borch-Johnsen and J. Jeppesen

Diabetic Medicine, 2012, 29(4), 479-487. DOI: 10.1111/j.1464-5491.2011.03513.x


Aim  To explore the putative association of new-onset diabetes and the soluble urokinase plasminogen activator receptor (suPAR), which is a new and stable plasma marker of immune function and low-grade inflammation. This association has been previously suggested by using the less sensitive International Classification of Disease system to detect incident diabetes in the Danish MONICA 10 cohort.

Methods  The Danish National Diabetes Register enabled more accurate identification of incident diabetes during a median follow-up of 13.8 years in the Danish MONICA 10 cohort (n = 2353 generally healthy individuals). The soluble urokinase plasminogen activator receptor was measured by the ELISA method. To fulfil model assumptions, outcome analyses were stratified by age, and further by smoking, owing to the interaction between the soluble urokinase plasminogen activator receptor and smoking on new-onset diabetes (P < 0.0001).

Results  New-onset diabetes (n = 182) was associated with increased soluble urokinase plasminogen activator receptor levels (P = 0.013). Among 699 middle-aged (41 and 51 years) and 564 older (61 and 71 years) non-smokers, participants in the upper soluble urokinase plasminogen activator receptor quartile had a sex- and age-adjusted relative risk of 6.01 (95% CI 2.17-16.6, P < 0.0006) and relative risk of 3.25 (95% CI 1.51-6.98, P = 0.0025), respectively, for new-onset diabetes compared with participants in the lowest quartile. This relationship remained significant after additional adjustments for C-reactive protein and leukocytes or fasting glucose and insulin or BMI (P < 0.05). The soluble urokinase plasminogen activator receptor was not related to incident diabetes among smokers (P ≥ 0.85).

Conclusions  In these explorative analyses, the soluble urokinase plasminogen activator receptor associated independently with incident diabetes in non-smokers, supporting an immune origin of Type 2 diabetes. Competing disease risk may explain lack of association among smokers.

ASCI-ID: 109-1016

View Fulltext

Similar Articles

Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study

Diabetic Medicine, 2011, 28(11), 1330-1336. DOI: 10.1111/j.1464-5491.2011.03343.x

Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and DESIR studies

Diabetic Medicine, 2011, 28(11), 1311-1318. DOI: 10.1111/j.1464-5491.2011.03403.x

Addressing insulin resistance in Type 1 diabetes

Diabetic Medicine, 2008, 25(9), 1015-1024.

Relationship between γ-glutamyltransferase and metabolic syndrome in a Korean population

Diabetic Medicine, 2008, 25(4), 469-475. DOI: 10.1111/j.1464-5491.2008.02415.x

Differential effect of β-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI

Diabetic Medicine, 2007, 24(7), 759-763. DOI: 10.1111/j.1464-5491.2007.02151.x

Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study

Diabetic Medicine, 2008, 25(5), 597-605. DOI: 10.1111/j.1464-5491.2008.02417.x

Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study

Diabetic Medicine, 2008, 25(5), 631-634. DOI: 10.1111/j.1464-5491.2008.02437.x

Mechanisms of glucose intolerance in cystic fibrosis

Diabetic Medicine, 2009, 26(6), 582-588. DOI: 10.1111/j.1464-5491.2009.02738.x

The effect of rosiglitazone on insulin sensitivity and mid-thigh low-density muscle in patients with Type 2 diabetes

Diabetic Medicine, 2010, 27(1), 30-36. DOI: 10.1111/j.1464-5491.2009.02897.x

Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?

Diabetic Medicine, 2010, 27(4), 417-422. DOI: 10.1111/j.1464-5491.2010.02979.x

Alcohol drinking, the metabolic syndrome and diabetes in a population with high mean alcohol consumption

Diabetic Medicine, 2010, 27(11), 1241-1249. DOI: 10.1111/j.1464-5491.2010.03094.x

Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes

Diabetic Medicine, 2011, 28(2), 148-155. DOI: 10.1111/j.1464-5491.2010.03143.x

Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies

Diabetic Medicine, 2011, 28(9), 1053-1059. DOI: 10.1111/j.1464-5491.2011.03346.x

The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates

Diabetic Medicine, 2011, 28(9), 1078-1081. DOI: 10.1111/j.1464-5491.2011.03315.x

Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus

Diabetic Medicine, 2012, 29(1), 36-42. DOI: 10.1111/j.1464-5491.2011.03473.x

Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose

Diabetic Medicine, 2008, 25(1), 73-79. DOI: 10.1111/j.1464-5491.2007.02329.x

Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity

Diabetic Medicine, 2008, 25(3), 289-295. DOI: 10.1111/j.1464-5491.2007.02380.x

Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey

Diabetic Medicine, 2008, 25(7), 798-804. DOI: 10.1111/j.1464-5491.2008.02471.x

Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects

Diabetic Medicine, 2008, 25(11), 1289-1294. DOI: 10.1111/j.1464-5491.2008.02597.x

Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy

Diabetic Medicine, 2009, 26(1), 79-82. DOI: 10.1111/j.1464-5491.2008.02621.x

Insulin resistance is an independent correlate of increased urine albumin excretion: a cross-sectional study in Iranian Type 2 diabetic patients

Diabetic Medicine, 2009, 26(2), 177-181. DOI: 10.1111/j.1464-5491.2008.02653.x

Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up

Diabetic Medicine, 2009, 26(4), 345-353. DOI: 10.1111/j.1464-5491.2009.02685.x

Altered respiratory function is associated with increased metabolic risk, independently of adiposity, fitness and physical activity

Diabetic Medicine, 2009, 26(4), 362-369. DOI: 10.1111/j.1464-5491.2009.02689.x

J-shaped relationship between waist circumference and subsequent risk for Type 2 diabetes: an 8-year follow-up of relatively lean Japanese individuals

Diabetic Medicine, 2009, 26(8), 753-759. DOI: 10.1111/j.1464-5491.2009.02773.x

Following in mother's footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes

Diabetic Medicine, 2010, 27(3), 257-265. DOI: 10.1111/j.1464-5491.2010.02944.x

The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments

Diabetic Medicine, 2010, 27(8), 918-924. DOI: 10.1111/j.1464-5491.2010.03047.x

Increased maternal Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) associated with older age at diagnosis of Type 1 diabetes in offspring

Diabetic Medicine, 2010, 27(12), 1450-1453. DOI: 10.1111/j.1464-5491.2010.03130.x

Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes

Diabetic Medicine, 2011, 28(5), 549-559. DOI: 10.1111/j.1464-5491.2010.03209.x

Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study

Diabetic Medicine, 2011, 28(6), 731-740. DOI: 10.1111/j.1464-5491.2011.03258.x

The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes

Diabetic Medicine, 2011, 28(8), 972-975. DOI: 10.1111/j.1464-5491.2011.03284.x

Sleep disturbances and insulin resistance

Diabetic Medicine, 2011, 28(12), 1455-1462. DOI: 10.1111/j.1464-5491.2011.03459.x

Insulin resistance and pathological brain ageing

Diabetic Medicine, 2011, 28(12), 1463-1475. DOI: 10.1111/j.1464-5491.2011.03464.x

Mechanistic insights into insulin resistance in the genetic era

Diabetic Medicine, 2011, 28(12), 1476-1486. DOI: 10.1111/j.1464-5491.2011.03463.x

Measurement of insulin action: a tribute to Sir Harold Himsworth

Diabetic Medicine, 2011, 28(12), 1487-1493. DOI: 10.1111/j.1464-5491.2011.03409.x

Impact of increased visceral and cardiac fat on cardiometabolic risk and disease

Diabetic Medicine, 2012, 29(5), 622-627. DOI: 10.1111/j.1464-5491.2011.03503.x

Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes

Diabetic Medicine, 2012, 29(8), 972-979. DOI: 10.1111/j.1464-5491.2012.03655.x

Hyperbaric oxygen therapy improves peripheral insulin sensitivity in humans

Diabetic Medicine, 2012, 29(8), 986-989. DOI: 10.1111/j.1464-5491.2012.03587.x

Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2009

Diabetic Medicine, 2012, 29(8), 1003-1010. DOI: 10.1111/j.1464-5491.2012.03575.x

" style="text-decoration:none">Dorothy Hodgkin Lecture 2012 Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management

Diabetic Medicine, 2012, 29(9), 1098-1107. DOI: 10.1111/j.1464-5491.2012.03732.x